Plasma Purification and Chronic Hepatitis B

• Status: Not yet recruiting
• Trial end date: 2023-09-30
• Target enrollment: 0
• Participant gender: All

Summary

To compare the efficacy of nucleoside analogues （HA） alone and plasma purification +HA in reducing HBV viral load.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Shanghai Pudong Hospital
• Treatments: Antiviral Agents

Criteria

Inclusion Criteria:

1. Clinical diagnosis of Chronic hepatitis B Disease

2. hepatitis B virus HBeAg is positive

3. hepatitis B virus HBV-DNA virus load is more than 100000cps/ml

Exclusion Criteria:

1. Hypotension

2. Cardiopulmonary insufficiency

3. Coagulation disorders

4. Heparin allergy